Original Investigation
Editorial Comment
TAVR Risk Assessment: Does the Eyeball Test Have 20/20 Vision, or Can We Do Better?∗

https://doi.org/10.1016/j.jacc.2016.05.030Get rights and content
Under an Elsevier user license
open archive

Key Words

aortic stenosis
predictors of mortality
transcatheter aortic valve implantation

Cited by (0)

Dr. Mack serves as the uncompensated co-principal investigator of the PARTNER-3 trial for Edwards Lifesciences; is the principal investigator of a national trial sponsored by Abbott Vascular; and serves as the uncompensated co-principal investigator of the COAPT trial of Abbott Vascular. Dr. Holper serves on the medical advisory board for Boston Scientific.

∗

Editorials published in the Journal of the American College of Cardiology reflect the views of the author and do not necessarily represent the views of JACC or the American College of Cardiology.

© 2016 by the American College of Cardiology Foundation